Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 1 year ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs. View more
Job title: Consultant Cardiologist & Electrophysiologist
Mauro Lencioni is a cardiologist at the Queen Elizabeth Hospital, Birmingham. His interests are the treatment of cardiac arrhythmias and the effects of arrhythmia symptoms on quality of life. View more
Author(s): Added: 3 months ago
AHA Conference 2024 - Primary safety and efficacy results from ENDEAVOR investigating the effect of myeloperoxidase inhibition with mitiperstat (AstraZeneca) on symptoms and exercise capacity in patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF).Dr Sanjiv Shah (Bluhm Cardiovascular Institute, Chicago, US) joins us onsite at AHA Conference to discuss the… View more
Angela Maas has been a cardiologist since 1988, specialising in heart disease in women. She holds a chair in cardiology for womenat Radboud University in Nijmegen, the Netherlands. The main focus of her work is cardiac symptoms in women at middle-age and the role of female-specific risk factors in (early) heart disease. She also founded an expert centre for microvascular coronary disease at the… View more
Job title: Interventional Cardiologist
Dr Simon Wilson is anInterventional Cardiologist atSt George's Hospital, London UK. Dr Wilson is dedicated to improving patient safety and outcomes and in 2021, was appointed the head of governance for cardiology at St George’s. His main focus is to help understand the cause of symptoms and deliver evidence-based treatment to improve quality of life and minimise the risk of future cardiac… View more
Author(s): Harriette Van Spall , Gregg Stone Added: 11 months ago
ACC 2024 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) welcomes Principal Investigator Dr Gregg Stone (Icahn School of Medicine at Mount Sinai, New York, NY, US) to discuss the REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure (NCT03499236) (V-Wave Ltd).The RELIEVE-HF trial aims to assess the safety and efficacy of a new device, the V-Wave… View more
Author(s): Harriette Van Spall , Mikhail Kosiborod Added: 1 year ago
ESC 2023 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss the findings from the STEP HFpEF trial (NCT04788511). Around half of patients with heart failure have heart failure with preserved ejection fraction (HFpEF), and most patients with HFpEF are overweight or obese. Patients with… View more
Research Area(s) / Expertise:

Cardio-oncology

Job title: Cardio-oncology Nurse
Kerry Skurka is a Cardio-oncology Nurse at Franciscan St. Francis Health in Franklin, US. With a professional career in cardiology nursing, Kerry transitioned to oncology following her own cancer experience. While treating cancer patients, she frequently encountered cardiac symptoms, which led her to become the first Cardio-oncology Nurse Navigator at Franciscan Health.In collaboration with… View more
Research Area(s) / Expertise:

Cardio-oncology

Job title: Department of Nursing, Division of SrVP and Chief Nursing Officer
Dr Anecita Fadol, PhD, FNP-BC, FAANP, FAAN is an Associate Professor in the department of nursing with a joint appointment in the department of cardiology at The University of Texas MD Anderson Cancer Center. Dr Fadol is a nursing pioneer in the evolving field of cardio-oncology. Her extensive and unique expertise in cardio-oncology have been recognised nationally and internationally. She has… View more
Author(s): Firas Zahr Added: 1 year ago
THT 24 - We are joined by Dr Firas Zahr (OHSU Knight Cardiovascular Institute Cardiology Clinic, US) to discuss the findings from the ALT FLOW Early Feasibility study (NCT03523416).The ALT FLOW Early Feasibility study aims to assess the initial clinical safety, functionality and effectiveness of a transcatheter atrial shunt system created by Edwards. 75 patients with symptomatic heart failure… View more